Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 Biomarker phenotype BEFREE Here, we characterize the functional cross-talk between FOXP3-c-MYC and TSC1-mTOR signaling during tumor progression. 30733194 2019
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 Biomarker phenotype BEFREE In conclusion we show that the c-MYC-NAMPT-DBC1-SIRT1 positive feedback loop contributes to murine serrated tumor progression. 31442917 2019
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 AlteredExpression phenotype BEFREE Our primary goal is to therapeutically target the oncogenic transcription factor MYC to stop tumor growth and cancer progression. 31790487 2019
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 AlteredExpression phenotype BEFREE Collectively, the findings in our study uncover that the RING domain of XIAP supports c-Myc protein stability, providing insight into the molecular mechanism and role of c-Myc overexpression in cancer progression. 30819803 2019
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 Biomarker phenotype BEFREE Over the last several decades, researchers have strived to define the context-dependent transcriptional gene programs that are controlled by MYC, as well as the mechanisms that regulate MYC function, in an effort to better understand the contribution of this oncoprotein to cancer progression. 31392631 2019
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 AlteredExpression phenotype BEFREE TEAD deregulation affects well-established cancer genes such as KRAS, BRAF, LKB1, NF2, and MYC, and its transcriptional output plays an important role in tumor progression, metastasis, cancer metabolism, immunity, and drug resistance. 31212916 2019
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 AlteredExpression phenotype BEFREE Our results establish ATF4 as a cellular rheostat of MYC activity, which ensures that enhanced translation rates are compatible with survival and tumour progression. 31263264 2019
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 AlteredExpression phenotype BEFREE This combination treatment resulted in suppression of AKT/mTOR signaling coupled with reduced expression of c-MYC, an oncoprotein implicated in tumor progression and therapeutic resistance. 30389701 2019
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 AlteredExpression phenotype BEFREE Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma. 29644114 2018
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 AlteredExpression phenotype BEFREE Myc gene signatures became upregulated on tumor progression in vivo and overexpression of Myc conferred resistance to entinostat in vitro. 30497520 2018
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 Biomarker phenotype BEFREE SEC inhibition downregulates MYC and MYC-dependent transcriptional programs in mammalian cells and delays tumor progression in a mouse xenograft model of MYC-driven cancer, indicating that small-molecule disruptors of SEC could be used for targeted therapy of MYC-induced cancer. 30340042 2018
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 Biomarker phenotype BEFREE In this review, we describe the mechanism of MYC activation in MM, the role of MYC in cancer progression, and the therapeutic options to targeting MYC. 29467490 2018
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 Biomarker phenotype BEFREE Moreover, increasing HH signaling in the stroma of PB-MYC PCa resulted in more intact SMC layers and decreased tumor progression (micro-invasive carcinoma). 27935821 2017
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 AlteredExpression phenotype BEFREE The far upstream element (FUSE)-binding protein 1 (FUBP1), a well-known transcriptional regulator of the proto-oncogene c-Myc, has been demonstrated by previous work to be aberrantly expressed in a variety of tumors and plays a critical role in tumor progression; however, its expression and function in relatively rare and aggressive chordomas remains unclear. 28780352 2017
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 Biomarker phenotype BEFREE Induction of PUMA gene and repression of MYC oncogene suggested that these complexes targeted different genes to suppress cancer progression. 28334655 2017
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 AlteredExpression phenotype BEFREE Targeted drug screening reveals that SCLC with high MYC expression is vulnerable to Aurora kinase inhibition, which, combined with chemotherapy, strongly suppresses tumor progression and increases survival. 28089889 2017
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 Biomarker phenotype BEFREE Pluripotency transcription factors NANOG, OCT4, MYC and SOX2 contribute to cancer progression by mitochondrial reprogramming leading to the genesis of TICs and cancer. 29256636 2017
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 Biomarker phenotype BEFREE Notably, switching off the oncogene in advanced carcinomas revealed that MYC was required for the continuous activation and repression of distinct sets of genes, constituting no more than half of all genes deregulated during tumor progression and an even smaller subset of all MYC-bound genes. 27197165 2016
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 AlteredExpression phenotype BEFREE In colorectal cancer, overexpression of c-MYC due to hyperactive WNT/β-catenin/TCF signaling is a key driver of tumor progression; however, effective strategies to target this oncogene remain elusive. 26983878 2016
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 Biomarker phenotype BEFREE MYC) that are dysregulated by rearrangements during tumor progression. 27353332 2016
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 GeneticVariation phenotype BEFREE While TP53 mutation and MYC amplification were synergistic in promoting tumor progression, PIK3CA mutation was found to have alleviated the oncogenic effect of either the TP53 mutation or MYC amplification, and was associated with a significant reduction in mitotic activity in TP53 mutated and/or MYC amplified breast cancer. 27283966 2016
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 AlteredExpression phenotype BEFREE The suppression of MYC by LKB1 controls epithelial organization; therefore, we hypothesize that MYC expression can be increased via wild-type LKB1 loss and promotes tumor progression. 24793789 2015
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 Biomarker phenotype BEFREE MYC expression is deregulated in more than 50% of human cancers, but the role of this protein in normal cell biology and tumor progression is still not well understood, in part because identifying MYC-interacting proteins has been technically challenging: MYC-containing chromatin-associated complexes are difficult to isolate using traditional affinity purification methods, and the MYC protein is exceptionally labile, with a half-life of only ~30 min. 25452129 2015
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 Biomarker phenotype BEFREE The pharmacologic inhibition of glutamine metabolism with bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide impeded MYC-mediated RCC tumor progression. 25964345 2015
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 Biomarker phenotype BEFREE TTF1 was involved in cancer progression via the RAS and MYC pathways in CRC, suggesting that TTF1 may be a prognostic indicator and therapeutic target in CRC. 26036188 2015